SYNB Putnam Biorevolution ETF

USD 30.27 0.00 0
Icon

Putnam Biorevolution ETF (SYNB) Stock Analysis and Price Targets

ETF | Others | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 30.27

0.00 (0.00)%

USD 5.43M

402.00

N/A

N/A

Icon

SYNB

Putnam Biorevolution ETF (USD)
ETF | NYE
USD 30.27
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 5.43M

N/A

USD 30.27

Putnam Biorevolution ETF (SYNB) Stock Forecast

N/A

Based on the Putnam Biorevolution ETF stock forecast from 0 analysts, the average analyst target price for Putnam Biorevolution ETF is not available over the next 12 months. Putnam Biorevolution ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Putnam Biorevolution ETF is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Putnam Biorevolution ETF’s stock price was USD 30.27. Putnam Biorevolution ETF’s stock price has changed by +2.67% over the past week, +0.54% over the past month and +10.68% over the last year.

No recent analyst target price found for Putnam Biorevolution ETF
No recent average analyst rating found for Putnam Biorevolution ETF

Company Overview Putnam Biorevolution ETF

The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries o...Read More

N/A

N/A

N/A

N/A

USD

USA

N/A

N/A

N/A

0.70 %

Adjusted Closing Price for Putnam Biorevolution ETF (SYNB)

Loading...

Unadjusted Closing Price for Putnam Biorevolution ETF (SYNB)

Loading...

Share Trading Volume for Putnam Biorevolution ETF Shares

Loading...

Compare Performance of Putnam Biorevolution ETF Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SYNB

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • 0%

Stocks Similar To Putnam Biorevolution ETF (Sector: Others )

Symbol Name Mer Price(Change) Market Cap
SOJE
SOJE 0.00 % 0.00 (0.00%) USD65.72B

ETFs Containing SYNB

Symbol Name SYNB's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Putnam Biorevolution ETF (SYNB) Stock

Stock Target Advisor's fundamental analysis for Putnam Biorevolution ETF's stock is Neutral.

SYNB stock's dividend yield is 0.07%. Our analysis grades SYNB stock's dividend yield at F. This means that SYNB stock's dividend yield is above 2% of the stocks in the Others sector in the NYE exchange. Based on this SYNB may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on SYNB's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on SYNB's stock to indicate if its overvalued.

The last closing price of SYNB's stock was USD 30.27.

The most recent market capitalization for SYNB is USD 5.43M.

Unfortunately we do not have enough analyst data on SYNB's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Putnam Biorevolution ETF's stock.

Sorry, we do not have any data on the number of employees for Putnam Biorevolution ETF.

Sorry we do not have any infomation available on Putnam Biorevolution ETF's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...